Co-Authors
This is a "connection" page, showing publications co-authored by YONG LI and XINFANG YU.
Connection Strength
4.054
-
PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. J Clin Invest. 2023 02 01; 133(3).
Score: 0.882
-
Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave. Biomedicines. 2021 Nov 16; 9(11).
Score: 0.811
-
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-?B activation and lymphomagenesis. Blood. 2021 03 25; 137(12):1615-1627.
Score: 0.775
-
Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation. J Hematol Oncol. 2020 05 01; 13(1):40.
Score: 0.728
-
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant. J Hematol Oncol. 2024 06 18; 17(1):45.
Score: 0.242
-
AI-powered discovery of a novel p53-Y220C reactivator. Front Oncol. 2023; 13:1229696.
Score: 0.228
-
Expanding anti-CD38 immunotherapy for lymphoid malignancies. J Exp Clin Cancer Res. 2022 Jun 28; 41(1):210.
Score: 0.211
-
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. Nat Commun. 2019 11 07; 10(1):5061.
Score: 0.176